<DOC>
	<DOCNO>NCT02613676</DOCNO>
	<brief_summary>In South Africa , healthy term newborn usually discharge early ( &lt; 72 hour delivery ) . Many study show hospital readmission rate increase practice , jaundice hyperbilirubinemia common cause readmission newborn . Peak serum bilirubin level usually occur postnatal day 3-5 , many already discharge put infant increase risk severe hyperbilirubinemia . Severe neonatal jaundice still constitute important cause neonatal mortality morbidity Africa . Screening newborn risk severe hyperbilirubinemia hospital could help early identification hyperbilirubinemia early intervention potentially prevent unwanted consequence like bilirubin induce neurological dysfunction . However , conflict recommendation use universal transcutaneous bilirubin screen jaundice newborn hospital discharge .</brief_summary>
	<brief_title>Transcutaneous Screening Risk Severe Hyperbilirubinemia South African Newborns</brief_title>
	<detailed_description>Like many country Africa rest world , objective screening risk severe hyperbilirubinemia use serum bilirubin ( TsB ) transcutaneous bilirubin ( TcB ) measurement currently standard care South Africa . The investigator therefore propose test use non-invasive TcB device detect predict risk severe jaundice discharge baby new-born nursery South African population newborn . OBJECTIVE To evaluate effect transcutaneous bilirubin screen newborns hospital discharge . METHODS In randomise control trial ( RCT ) investigator compare traditional visual assessment TcB measurement hospital discharge . About 1858 newborn ≥35 week gestational age and/or ≥1800 g , &lt; 72 hrs life randomly allocate two group : ) TcB screening , b ) visual assessment ( standard care ) Subjects : Babies ≥ 35 wks gestational age and/or ≥ 1800g , &lt; 72 hrs life . Study arm : Participants randomise within 72 hrs birth : ) TcB screen plot nomogram b ) visual assessment jaundice . Control group ( Standard care ) : In group , participant assess jaundice use traditional visual assessment discharge . A formal serum bilirubin level do infant visibly jaundice decide need phototherapy . TcB screen group : All participant group , assess risk severe hyperbilirubinemia measurement bilirubin level use JM 105 transcutaneous device &lt; 72 hrs life hospital discharge . The bilirubin level plot Bhutani hour-specific nomogram determine risk zone . Babies classify four different different risk category : high-risk , high-intermediate , low-intermediate low risk category depend transcutaneous bilirubin level . Follow-up intervention plan base risk category . For participant identify high risk severe hyperbilirubinemia , investigator perform formal TsB measurement determine need phototherapy .</detailed_description>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Jaundice , Neonatal</mesh_term>
	<mesh_term>Bilirubin</mesh_term>
	<criteria>All newborn ≥ 35 wks gestational age ≥ 1800g Babies &lt; 72 hour life Prior use phototherapy Major congenital anomaly Babies bear &lt; 35 wks gestational age &lt; 1800g</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>